A Basel-led international research team has discovered a connection between the intestinal flora and sites of inflammation in the central nervous system in multiple sclerosis. A specific class of immune cell plays a central role in this newly identified gut-brain axis. The discovery could pave the way for new treatments for MS that target the intestinal flora.
A new study from Tel Aviv University (TAU) and the Shamir Medical Center in Israel indicates that hyperbaric oxygen treatments (HBOT) in healthy aging adults can stop the aging of blood cells and reverse the aging process. In the biological sense, the adults' blood cells actually grow younger as the treatments progress.
A mutation in the CLCN6 gene is associated with a novel, particularly severe neurodegenerative disorder. Scientists from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and the Max Delbrück Center für Molekulare Medizin (MDC), together with an international team of researchers, have now analyzed the effect of a point mutation that was found in three unrelated affected children.
Meeting a 100-year-old challenge could lead the way to digital aromas
Researchers at Tokyo Medical and Dental University (TMDU) have identified a protein called Wipi3 that is essential for cellular waste disposal via the alternative autophagy system. Deletion of Wipi3 in the brains of mice causes growth and motor defects attributed to neuronal accumulation of iron, resulting in neurodegeneration. However, over-expression of another alternative autophagy protein, Dram1, reverses the effects in Wipi3 deficiency, and may represent a novel treatment for neurodegenerative diseases.
UCLA scientists and colleagues found the use of long-acting antipsychotic medication combined with the use of cognitive training in group settings led to improved cognition and increased productivity.
A study found a significant increase in the number of online search queries for "insomnia" between April and May 2020, when governments across the U.S. and around the world implemented stay-at-home orders in response to the COVID-19 pandemic.
Tufts researchers find a key mutation causing abnormal transport of BACE1, the enzyme responsible for processing the Alzheimer's disease-linked amyloid protein. Identification of this mutation, which is more common among African Americans with Alzheimer's, may allow early intervention.
Some patients with COVID-19 are at higher risk of neurological complications like bleeding in the brain and stroke, according to a study being presented at the annual meeting of the Radiological Society of North America (RSNA). The researchers said these potentially life-threatening findings were more common in patients with hypertension and diabetes.
Older women who live in locations with higher levels of air pollution may have more brain shrinkage, the kind seen in Alzheimer's disease, than women who live in locations with lower levels, according to a new study published in the November 18, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.